Asarfi Hospital Ltd Stock Price Today (NSE: ASARFI)
Fundamental Score
Asarfi Hospital Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Asarfi Hospital Ltd share price today is ₹169.55, down 0.08% on NSE/BSE as of 30 March 2026. Asarfi Hospital Ltd (ASARFI) is a Small-cap company in the Hospital sector with a market capitalisation of ₹384.79 (Cr). The 52-week high for ASARFI share price is ₹221.00 and the 52-week low is ₹72.90. At a P/E ratio of 27.39x, ASARFI is currently trading below its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 14.06% and a debt-to-equity ratio of 0.54.
Asarfi Hospital Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Asarfi Hospital Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Asarfi Hospital Share Price Analysis: A ROCE-Focused Perspective
The Indian hospital sector, facing increasing demand driven by an aging population and rising healthcare awareness, is witnessing significant investor interest. This analysis focuses on the "Asarfi Hospital share price," currently at ₹187.9499969482422, utilizing a Return on Capital Employed (ROCE) lens. The hospital's Price-to-Earnings (PE) ratio stands at 27.39, alongside a ROCE of 15.83%. This report is part of a broader 80-parameter fundamental audit verified by Sweta Mishra.
A key metric for evaluating a hospital's operational efficiency is ROCE. Asarfi Hospital's ROCE of 15.83% indicates the profitability generated from its capital investments. A consistently high ROCE can be viewed as a component to the organization's business moat. This implies efficient capital deployment, suggesting the management team is effectively generating returns from its assets. This ability to generate superior returns could translate to sustained growth and competitive advantage over time. However, ROCE should be viewed in conjunction with other metrics to form a holistic assessment.
Comparing Asarfi Hospital to its peers provides further context. While a detailed management quality assessment requires more in-depth analysis, contrasting it with
Nephro Care India Limited on factors such as capital allocation strategies and operational execution could highlight relative strengths and weaknesses. For instance, if Nephro Care India Limited demonstrates a history of more strategic acquisitions and superior cost management, it might suggest a difference in management acumen. This is only observational; further analysis on factors is needed.In conclusion, the 15.83% ROCE for Asarfi Hospital provides a crucial insight into its financial health and operational efficiency. It signifies how effectively the company utilizes its capital to generate profits. The comparison with peers like Strategic Minerals Plc and Abateas Industries Ltd would further sharpen the understanding of Asarfi Hospital's relative performance within the industry. Future analysis should involve more granular evaluation of the hospital’s operational metrics, financial statements, management quality and other relevant quantitative and qualitative parameters.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Asarfi Hospital Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ASARFI across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Excellent ROCE Performance (15.83%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (18.82%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 27.39 vs Industry: 52.84)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (48.28%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (45.33%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (22.13% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (32.35% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Balanced Promoter Holding (61.17%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Weak Earnings Growth (-24.05% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-55.41 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 2.23%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Asarfi Hospital Ltd Financial Statements
Comprehensive financial data for Asarfi Hospital Ltd including income statement, balance sheet and cash flow
About ASARFI (Asarfi Hospital Ltd)
Asarfi Hospital Ltd is a beacon of healthcare accessibility nestled in the heart of Dhanbad, India. Established with a commitment to serve the local community, the hospital functio...ns as a multifaceted healthcare provider, exceeding the conventional boundaries of mere treatment. Asarfi distinguishes itself by emphasizing preventive care and health education, actively engaging with the population to foster a culture of well-being. From basic medical consultations to comprehensive health initiatives, the hospital strives to be the first point of contact for individuals seeking support on their journey to improved health. The organization's presence reflects a dedication to building a healthier future for the people it serves, prioritizing holistic care over a purely reactive approach to illness. Beyond its core medical services, Asarfi Hospital Ltd extends its reach through various community-focused programs. These initiatives include regular health camps designed to bring essential medical check-ups to underserved areas, along with crucial drug distribution programs to ensure medication access. The hospital also champions health and hygiene awareness, offering educational programs that promote healthy practices and prevent the spread of diseases. Recognizing the importance of holistic well-being, Asarfi incorporates yoga and exercise centers, allowing individuals to incorporate physical activity into their lifestyles. These diverse activities show their determination to impact the community. Asarfi Hospital Ltd acts as a health information resource for the people of Dhanbad and its surrounding areas. The hospital works to provide medical care, and also empowers individuals with the knowledge they need to make informed decisions about their health. By making preventative care a core principle, Asarfi Hospital Ltd is working to create a future where quality healthcare is available to everyone.
Company Details
Key Leadership
Latest News
ASARFI Share Price: Frequently Asked Questions
What is the current share price of Asarfi Hospital Ltd (ASARFI)?
As of 30 Mar 2026, 12:02 pm IST, Asarfi Hospital Ltd share price is ₹169.55. The ASARFI stock has a market capitalisation of ₹384.79 (Cr) on NSE/BSE.
Is ASARFI share price Overvalued or Undervalued?
ASARFI share price is currently trading at a P/E ratio of 27.39x, compared to the industry average of 52.84x. Based on this relative valuation, the Asarfi Hospital Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of ASARFI share price?
The 52-week high of ASARFI share price is ₹221.00 and the 52-week low is ₹72.90. These values are updated daily from NSE/BSE price data.
What factors affect the Asarfi Hospital Ltd share price?
Key factors influencing ASARFI share price include quarterly earnings growth (Sales Growth: 45.33%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Asarfi Hospital Ltd a good stock for long-term investment?
Asarfi Hospital Ltd shows a 5-year Profit Growth of 32.35% and an ROE of 14.06%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.54 before investing in ASARFI shares.
How does Asarfi Hospital Ltd compare with its industry peers?
Asarfi Hospital Ltd competes with major peers in the Hospital. Investors should compare ASARFI share price P/E of 27.39x and ROE of 14.06% against the industry averages to determine competitive standing.
What is the P/E ratio of ASARFI and what does it mean?
ASARFI share price has a P/E ratio of 27.39x compared to the industry average of 52.84x. Investors pay ₹27 for every ₹1 of annual earnings.
How is ASARFI performing according to Bull Run's analysis?
ASARFI has a Bull Run fundamental score of 66.3/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ASARFI belong to?
ASARFI operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Asarfi Hospital Ltd share price.
What is Return on Equity (ROE) and why is it important for ASARFI?
ASARFI has an ROE of 14.06%, which shows decent profitability but room for improvement. ROE measures how efficiently Asarfi Hospital Ltd generates profits from shareholders capital.
How is ASARFI debt-to-equity ratio and what does it indicate?
ASARFI has a debt-to-equity ratio of 0.54, which indicates moderate leverage that should be monitored.
What is ASARFI dividend yield and is it a good dividend stock?
ASARFI offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Asarfi Hospital Ltd shares.
How has ASARFI share price grown over the past 5 years?
ASARFI has achieved 5-year growth rates of: Sales Growth 22.13%, Profit Growth 32.35%, and EPS Growth -24.05%.
What is the promoter holding in ASARFI and why does it matter?
Promoters hold 61.17% of ASARFI shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Asarfi Hospital Ltd.
What is ASARFI market capitalisation category?
ASARFI has a market capitalisation of ₹385 crores, placing it in the Small-cap category.
How volatile is ASARFI stock?
ASARFI has a beta of N/A. A beta > 1 suggests the Asarfi Hospital Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ASARFI operating profit margin trend?
ASARFI has a 5-year average Operating Profit Margin (OPM) of 18.82%, indicating the company's operational efficiency.
How is ASARFI quarterly performance?
Recent quarterly performance shows Asarfi Hospital Ltd YoY Sales Growth of 45.33% and YoY Profit Growth of 48.28%.
What is the institutional holding pattern in ASARFI?
ASARFI has FII holding of 0.05% and DII holding of 2.18%. Significant institutional holding often suggests professional confidence in the Asarfi Hospital Ltd stock.